Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 2
1966 2
1968 1
1980 1
1985 5
1986 7
1987 5
1988 1
1989 3
1990 2
1992 2
1995 1
1999 2
2001 2
2003 1
2004 1
2005 1
2008 2
2014 1
2015 1
2016 1
2017 1
2018 1
2021 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS; ECOSPOR III and ECOSPOR IV investigators. Kraft CS, et al. Infect Dis Ther. 2024 Oct;13(10):2105-2121. doi: 10.1007/s40121-024-01007-z. Epub 2024 Jun 28. Infect Dis Ther. 2024. PMID: 38941068 Free PMC article.
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS; ECOSPOR III and ECOSPOR IV investigators. Kraft CS, et al. Infect Dis Ther. 2024 Oct;13(10):2209-2210. doi: 10.1007/s40121-024-01036-8. Infect Dis Ther. 2024. PMID: 39212853 Free PMC article. No abstract available.
Nasal amphotericin irrigation in chronic rhinosinusitis.
Stankiewicz JA, Musgrave BK, Scianna JM. Stankiewicz JA, et al. Among authors: musgrave bk. Curr Opin Otolaryngol Head Neck Surg. 2008 Feb;16(1):44-6. doi: 10.1097/MOO.0b013e3282f1c7ba. Curr Opin Otolaryngol Head Neck Surg. 2008. PMID: 18197021 Review.
Language games.
Musgrave BS, Emmart B. Musgrave BS, et al. Am Psychol. 1968 Aug;23(8):587-8. doi: 10.1037//0003-066x.23.8.587. Am Psychol. 1968. PMID: 5665433 No abstract available.
Tau-neutrino mass limit.
Abachi S, Baringer P, Bylsma BG, De Bonte R, Koltick D, Loeffler FJ, Low EH, McIlwain RL, Miller DH, Ng CR, Rangan LK, Shibata EI, Derrick M, Gan KK, Kooijman P, Loos JS, Musgrave B, Price LE, Repond J, Sugano K, Blockus D, Brabson B, Brom J, Jung C, Ogren H, Paik HW, Rust DR, Akerlof C, Chapman J, Errede D, Ken MT, Meyer DI, Nitz D, Thun R, Tschirhart R, Cork B. Abachi S, et al. Among authors: musgrave b. Phys Rev D Part Fields. 1987 May 1;35(9):2880-2882. doi: 10.1103/physrevd.35.2880. Phys Rev D Part Fields. 1987. PMID: 9958000 No abstract available.
52 results